人格支持心理干预(PSP)与常规治疗对照的可行性随机对照试验研究方案
本研究为两臂平行组单盲随机对照试验方案,旨在评估低强度干预PSP对比常规治疗(TAU)在人格障碍患者中的可行性。研究对象为18岁以上、使用二级精神卫生服务的人格障碍患者,随机后24周进行单次盲法随访评估。主要可行性指标为招募率、治疗参与度和保留率,并探索结局指标分布以为未来确证性试验的样本量规划提供依据。
要点
- PSP是经广泛咨询后开发的低强度人格障碍干预,旨在弥补现有高强度治疗可及性不足的问题。
- 试验采用远程系统1:1随机,按转诊团队和性别分层,24周时由盲法研究者进行单次随访评估。
- 可行性主要依据招募率及治疗参与和保留情况判断,结局指标分布用于规划未来确证性试验。
核心结论
- 本研究旨在检验PSP对比TAU用于人格障碍患者的随机对照试验可行性,为未来确证性试验的规划与样本量估算提供依据。
研究设计与样本
- 两臂平行组单盲随机对照试验,PSP与TAU按1:1随机,按转诊团队和参与者性别分层。
- 纳入18岁以上、使用二级精神卫生服务且患人格障碍者;排除共病器质性或精神病性障碍、认知或语言困难影响知情同意或研究参与、以及已在接受人格障碍心理治疗者。
- 随机后24周由盲法研究者进行单次随访评估。
关键数值与推荐
- 可行性主要依据研究招募率及治疗参与和保留情况判断。
- 结局评估包括Warwick-Edinburgh幸福感量表、工作与社会适应量表、EQ-5D-5L、自杀行为发生率、客户满意度问卷、成人服务使用量表修改版资源使用与费用、以及患者版临床总体印象量表。
- 分析主要关注招募率、参与者特征、脱落、治疗依从性和随访的描述性数据,并探索结局分布以检验正态性假设。
临床怎么用
- 当前多数人格障碍患者未获得循证干预,亟需开发低强度方法帮助无法使用现有治疗者。
- PSP为个体低强度干预,系与人格障碍服务使用者和提供者广泛咨询后开发。
局限性
- 本研究为可行性试验方案,主要关注招募、参与和保留等可行性指标,而非临床有效性检验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous research has demonstrated the clinical effectiveness of long-term psychological treatment for people with some types of personality disorder. However, the high intensity and cost of these interventions limit their availability. Lower-intensity interventions are increasingly being offered to people with personality disorder, but their clinical and cost effectiveness have not been properly tested in experimental studies. We therefore set out to develop a low intensity intervention for people with personality disorder and to test the feasibility of conducting a randomized controlled trial to compare the clinical effectiveness of this intervention with that of treatment as usual (TAU). METHODS: A two-arm, parallel-group, single-blind, randomized controlled trial of Psychological Support for Personality (PSP) versus TAU for people aged over 18 years, who are using secondary care mental health services and have personality disorder. We will exclude people with co-existing organic or psychotic mental disorders (dementia, bipolar affective disorder, delusional disorder, schizophrenia, schizoaffective disorder, or schizotypal disorder), those with cognitive or language difficulties that would preclude them from providing informed consent or compromise participation in study procedures, and those who are already receiving psychological treatment for personality disorder. Participants will be randomized via a remote system in a ratio of PSP to TAU of 1:1. Randomization will be stratified according to the referring team and gender of the participant. A single follow-up assessment will be conducted by masked researchers 24 weeks after randomization to assess mental health (using the Warwick and Edinburgh Well-Being Schedule), social functioning (using the Work and Social Adjustment Scale), health-related quality of life (EQ-5D-5 L), incidence of suicidal behavior, satisfaction with care (Client Satisfaction Questionnaire), and resource use and costs using a modified version of the Adult Service Use Schedule. In addition to this, each participant will be asked to complete the patient version of the Clinical Global Impression Scale. Feasibility and acceptability will primarily be judged by study recruitment rate and engagement and retention in treatment. The analysis will focus principally on descriptive data on the rate of recruitment, characteristics of participants, attrition, adherence to therapy, and follow-up. We will explore the distribution of study outcomes to investigate assumptions of normality in order to plan the analysis and sample size of a future definitive trial. DISCUSSION: Most people with personality disorder do not currently receive evidence-based interventions. While a number of high intensity psychological treatments have been shown to be effective, there is an urgent need to develop effective low intensity approaches to help people unable to use existing treatments. PSP is a low intensity intervention for individuals, which was developed following extensive consultation with users and providers of services for people with personality disorder. This study aims to examine the feasibility of a randomized trial of PSP compared to TAU for people with personality disorder. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN14994755 . Registered on 18 July 2017.
引用
- Crawford MJ, Thana L, Parker J, et al. Psychological Support for Personality (PSP) versus treatment as usual: study protocol for a feasibility randomized controlled trial of a low intensity intervention for people with personality disorder. Trials. 2018. PMID: 30305148. doi:10.1186/s13063-018-2920-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。